Clinical Pharmacy in 2011! Good day friends. I have not written for a long time but I felt like writing today in response to Sri Bhagavan's call. We have started doing patient counseling with this year's batch of III year students in our dispensary. I do not know about other colleges but in our college it is a challenge to find the time to train the students. Both I and my students- we are full of enthusiasm, but we do not find the time. Anyway, we started. This is what I did. In introductory classes I told them what patient counseling means. Then I took them to the pharmacy in our dispensary and made them enter all the brand names, corresponding generic names and categories. I told them to learn them well. Then for each category, I told them how to do counseling. Now we started to do counseling; they are at the present observing me and other senior scholars do counseling. Later they will do it themselves. We are also giving height- weight counseling. To diabetic people, we are giving counseling based on a prepared brochure. My feeling is that the patients are appreciating our presence. They happily take our brochure and go home. Another field of activity is, we are taking out II year Pharm D students to King George Hospital once in a week. We trained them since last year to do brochure based counseling to Diabetics. They are doing it well now. This year they will spend time in hospital understanding prescriptions also. Last month I attended a workshop on experiential learning by Pharm D students in Mysore JSS college. To put it in a nutshell, it was impressed upon all of us, by the international speakers, that most of the learning by Pharm D students happens through experiencing rather than through class room learning. It was also impressed upon me that we must go beyond patient counseling. I am wondering whether we can start adverse drug reaction monitoring with the help of M.Pharm students. A few colleagues pointed out that doctors may not like this activity. But my own experience with doctors in KGH is that they are friendly and cordial. I am now a member of the ethics committee of KGH also. The doctors listen to my opinion and I feel proud that I am able to contribute something on that platform also. I find that there are some points, like CDSCO guidelines on clinical trials and some points about pharmacoeconomics that I am able to give to the committee. I invite opinions on whether adverse drug monitoring can be a worthwhile activity or not. How can we plan to make it a success? Vijaya Ratna
Clinical Pharmacy in 2011!